European Heart Journal Advance Access published online on June 24, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi389
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Clinical Cardiology, NHLI, Imperial College School of Medicine, London, UK; Department of Cardiology, Friedrich-Schiller University, Erlanger Allee 101, D-07740 Jena, Germany
* To whom correspondence should be addressed. Chronic heart failure (CHF) is a multi-organ disease with increasing evidence for the involvement of the gastrointestinal (GI) system in this syndrome. In recent research, the gut has received very little attention from cardiologists as its role in the pathogenesis of cardiovascular disease is poorly understood. Intestinal ischaemia may play an important role in bacterial translocation by increasing bowel permeability. Decreased cardiac function can reduce bowel perfusion and so clearly impairs the function of the intestinal barrier. There is an increasing evidence to suggest that a leaky bowel wall may lead to translocation of bacteria and/or endotoxin, which may be an important stimulus for inflammatory cytokine activation in CHF. Impaired functioning of the GI system may also contribute to malnutrition and cachexia in CHF. It is hoped that by improving our understanding of the role of the gut in cardiac disease will lead to the development of novel therapeutic strategies in the future.
Received March 26, 2005
Revised May 29, 2005
Accepted June 2, 2005
Review
The importance of the gastrointestinal system in the pathogenesis of heart failure
2 Clinical Cardiology, NHLI, Imperial College School of Medicine, London, UK
3 Department of Cardiology, Friedrich-Schiller University, Erlanger Allee 101, D-07740 Jena, Germany
4 Clinical Cardiology, NHLI, Imperial College School of Medicine, London, UK; Applied Cachexia Research, Department of Cardiology, Charite Campus, Berlin, Germany
Andreas Krack, E-mail: andreas.krack{at}med.uni-jena.de
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. J. van Essen, J. C. M. Vernooij, J. A. P. Heesterbeek, D. Anjema, D. Merkus, and D. J. Duncker Does cardiovascular performance of modern fattening pigs obey allometric scaling laws? J Anim Sci, June 1, 2009; 87(6): 1991 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Dunn, B. Bleske, M. Dorsch, T. Macaulay, B. Van Tassell, and O. Vardeny Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies Nutr Clin Pract, February 1, 2009; 24(1): 60 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Pagourelias, C. Koumaras, A. I. Kakafika, K. Tziomalos, P. G. Zorou, V. G. Athyros, and A. Karagiannis Cardiorenal Anemia Syndrome: Do Erythropoietin and Iron Therapy Have a Place in the Treatment of Heart Failure? Angiology, February 1, 2009; 60(1): 74 - 81. [Abstract] [PDF] |
||||
![]() |
E. F. Rosa, E. Freymuller, S. S. M. Ihara, J. Aboulafia, and V. L. A. Nouailhetas Damaging effects of intense repetitive treadmill running on murine intestinal musculature J Appl Physiol, May 1, 2008; 104(5): 1410 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Addisu, W. R. Gower Jr., C. S. Landon, and J. R. Dietz B-Type Natriuretic Peptide Decreases Gastric Emptying and Absorption Experimental Biology and Medicine, April 1, 2008; 233(4): 475 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. von Haehling, W. Doehner, and S. D Anker Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure Cardiovasc Res, January 15, 2007; 73(2): 298 - 309. [Abstract] [Full Text] [PDF] |
||||





